Challenges of driving CD30-directed CAR-T cells to the clinic

por Grover, Natalie S., Savoldo, Barbara
Publicado 2019

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy

por Grover, Natalie S., Park, Steven I.
Publicado 2015

How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy

por Gutierrez, Cristina, Neilan, Tomas G., Grover, Natalie S.
Publicado 2023

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

por Meier, Jeremy A., Savoldo, Barbara, Grover, Natalie S.
Publicado 2022

Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient

por Forster, Moriah, Fedoriw, Yuri, Tuchman, Sascha, Grover, Natalie
Publicado 2022

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem...

por Coombs, Catherine C., Easaw, Saumya, Grover, Natalie S., O’Brien, Susan M.
Publicado 2023

Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies

por Schorr, Christopher, Forindez, Jorge, Espinoza-Gutarra, Manuel, Mehta, Rakesh, Grover, Natalie, Perna, Fabiana
Publicado 2023

A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus

por Dittus, Christopher, Grover, Natalie, Sethi, Tarsheen, Cohen, Jonathon B., Voloschin, Alfredo, Rabadey, Janhvi, Tan, Xianming, Beaven, Anne, Park, Steven I.
Publicado 2022

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts

por Martin, Peter, Cohen, Jonathon B., Wang, Michael, Kumar, Anita, Hill, Brian, Villa, Diego, Switchenko, Jeffrey M., Kahl, Brad, Maddocks, Kami, Grover, Natalie S., Qi, Keqin, Parisi, Lori, Daly, Katherine, Zhu, Angeline, Salles, Gilles
Publicado 2023

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas

por Tschernia, Nicholas P, Heiling, Hillary, Deal, Allison M, Cheng, Catherine, Babinec, Caroline, Gonzalez, Megan, Morrison, J Kaitlin, Dittus, Christopher, Dotti, Gianpietro, Beaven, Anne W, Serody, Jonathan S, Wood, William A, Savoldo, Barbara, Grover, Natalie S
Publicado 2023

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

por Wood, William A., Dilip, Deepika, Derkach, Andriy, Grover, Natalie S., Elemento, Olivier, Levine, Ross, Thanarajasingam, Gita, Batsis, John A., Bailey, Charlotte, Kannappan, Arun, Devine, Steven M., Artz, Andrew S., Ligibel, Jennifer A., Basch, Ethan, Kent, Erin, Glass, Jacob
Publicado 2023

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

por Voorhees, Timothy J., Zhao, Beibo, Oldan, Jorge, Hucks, George, Khandani, Amir, Dittus, Christopher, Smith, Jennifer, Morrison, J. Kaitlin, Cheng, Catherine J., Ivanova, Anastasia, Park, Steven, Shea, Thomas C., Beaven, Anne W., Dotti, Gianpietro, Serody, Jonathan, Savoldo, Barbara, Grover, Natalie
Publicado 2022

S220: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: A CIBMTR SUBGROUP ANALYSIS BY PRIOR TREATMENT

por Ahmed, Nausheen, Kambhampati, Swetha, Hamadani, Mehdi, Grover, Natalie, Shadman, Mazyar, Locke, Frederick, Gerson, James, Frank, Matthew J., Budde, L. Elizabeth, Wang, Michael, Hu, Zhen-Huan, Nunes, Ana, Dalton, David, Kloos, Ioana, Lee, Daniel, Xu, Hairong, Pasquini, Marcelo, Herrera, Alex F.
Publicado 2023

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

por Annunzio, Kaitlin, Grover, Natalie S., Welkie, Rina Li, Torka, Pallawi, Watkins, Marcus P., Anampa-Guzmán, Andrea, Tavakkoli, Montreh, Oh, Timothy S., Reves, Heather, Jones, Daniel, Hanel, Walter, Christian, Beth, Ramakrishnan Geethakumari, Praveen, Karmali, Reem, Barta, Stefan K., Bartlett, Nancy L., Olszewski, Adam J., Epperla, Narendranath
Publicado 2023

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

por Epperla, Narendranath, Zhao, Qiuhong, Karmali, Reem, Torka, Pallawi, Shea, Lauren, Oh, Timothy S., Anampa-Guzmán, Andrea, Reves, Heather, Tavakkoli, Montreh, Greenwell, Irl Brian, Hansinger, Emily, Umyarova, Elvira, Annunzio, Kaitlin, Sawalha, Yazeed, Christian, Beth, Thomas, Colin, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

por Sawalha, Yazeed, Goyal, Subir, Switchenko, Jeffrey M., Romancik, Jason T., Kamdar, Manali, Greenwell, I. Brian, Hess, Brian T., Isaac, Krista M., Portell, Craig A., Mejia Garcia, Alex, Goldsmith, Scott, Grover, Natalie S., Riedell, Peter A., Karmali, Reem, Burkart, Madelyn, Buege, Michael, Akhtar, Othman, Torka, Pallawi, Kumar, Anita, Hill, Brian T., Kahl, Brad S., Cohen, Jonathon B.
Publicado 2023

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis

por Hamadani, Mehdi, Gopal, Ajay K., Pasquini, Marcelo, Kim, Soyoung, Qiu, Xianmiao, Ahmed, Sairah, Lazaryan, Aleksandr, Bhatt, Vijaya Raj, Daly, Andrew, Lulla, Premal, Ciurea, Stefan, Gauthier, Jordan, Agrawal, Vaibhav, Grover, Natalie S., Lekakis, Lazaros, Modi, Dipenkumar, Dahi, Parastoo B., Herr, Megan M., Johnson, P. Connor, Hashmi, Hamza, Hematti, Peiman, Locke, Frederick L.
Publicado 2022

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study

por Epperla, Narendranath, Welkie, Rina Li, Torka, Pallawi, Shouse, Geoffrey, Karmali, Reem, Shea, Lauren, Anampa-Guzmán, Andrea, Oh, Timothy S., Reaves, Heather, Tavakkoli, Montreh, Lindsey, Kathryn, Greenwell, Irl Brian, Hansinger, Emily, Thomas, Colin, Chowdhury, Sayan Mullick, Annunzio, Kaitlin, Christian, Beth, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Herrera, Alex F., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

por Bond, David A., Switchenko, Jeffrey M., Villa, Diego, Maddocks, Kami, Churnetski, Michael, Gerrie, Alina S., Goyal, Subir, Shanmugasundaram, Krithika, Calzada, Oscar, Kolla, Bhaskar, Bachanova, Veronika, Gerson, James N., Barta, Stefan K., Hill, Brian T., Sawalha, Yazeed, Martin, Peter, Maldonado, Edward, Gordon, Max, Danilov, Alexey V., Grover, Natalie S., Mathews, Stephanie, Burkart, Madelyn, Karmali, Reem, Ghosh, Nilanjan, Park, Steven I., Epperla, Narendranath, Badar, Talha, Guo, Jin, Hamadani, Mehdi, Fenske, Timothy S., Malecek, Mary-Kate, Kahl, Brad S., Flowers, Christopher R., Blum, Kristie A., Cohen, Jonathon B.
Publicado 2021

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

por Epperla, Narendranath, Switchenko, Jeffrey, Bachanova, Veronika, Gerson, James N., Barta, Stefan K., Gordon, Max J., Danilov, Alexey V., Grover, Natalie S., Mathews, Stephanie, Burkart, Madelyn, Karmali, Reem, Sawalha, Yazeed, Hill, Brian T., Ghosh, Nilanjan, Park, Steven I., Bond, David A., Hamadani, Mehdi, Fenske, Timothy S., Martin, Peter, Malecek, Mary-Kate, Kahl, Brad S., Flowers, Christopher R., Link, Brian K., Kaplan, Lawrence D., Inwards, David J., Feldman, Andrew L., Hsi, Eric D., Maddocks, Kami, Blum, Kristie A., Bartlett, Nancy L., Cerhan, James R., Leonard, John P., Habermann, Thomas M., Maurer, Matthew J., Cohen, Jonathon B.
Publicado 2022